Conference Call with Krishna Institute of Medical Sciences Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Krishna Institute of Medical Sciences announced Q1FY25 results: Financial Highlights: Consolidated Revenue from Operations grew by 13.6% on a YoY and 8.6% on a QoQ basis to Rs 688 crore Consolidated EBITDA (Pre-INDAS) declined by 0.4% on a YoY and grew by 0.9% on a QoQ basis to 176.6 crore Consolidated EBITDA (Pre-INDAS and excluding Other Income) Margin stands at 25.0%, a decrease of 0.6% YoY and growth of 0.9% QoQ. Gross revenue of Rs 693 crore, a growth of 13.8% on YoY and 8.7% on QoQ basis. EBITDA of Rs 184 crore, a growth of 14.9% on YoY and 13.0% on QoQ basis. EBITDA margin at 26.6% vs. 26.3% in Q1 FY24 and 25.5% in Q4 FY24. EBITDA Margin (excluding Other Income) stands at 26.1%, a growth of 0.1% on YoY and 1.0% on QoQ. PAT at Rs 95.1 crore in Q1 FY25 against Rs 86.7 crore and Rs 71.6 crore in Q1 FY24 and Q4 FY24 respectively. Consolidated EPS of Rs 10.8, a growth of 7.0% on YoY and 32.1% on QoQ basis. Bed occupancy in Q1 FY25 at 49.8%, declined by 3.2% on YoY and 1.7% QoQ basis. Cash and Cash Equivalents (includes Cash, Bank balance, Deposits with maturity less than 12 months and Investment in Mutual funds) at Rs 185 crore in Q1 FY25. Operational Highlights: ARPOB grew by 21.3% and 12.2% on YoY and QoQ basis respectively ARPP grew by 6.1% and 1.4% on YoY and QoQ basis respectively IP Volume grew by 7.5% and 7.1% on YoY and QoQ basis respectively Conducted 4.2 lakhs OPD consults in Q1 FY25, which grew by 10.2% on YoY and 2.6% on QoQ basis. Announcing Q1 FY 25 results, B Bhaskar Rao, CMD, KIMS Hospitals, said: FY 25 has begun on a robust note. Most of our units have performed as per targets, especially the newer ones of Nagpur and Sunshine. Clinical additions to key departments over the last few quarters have helped us serve our patients better and add to our topline too. Nashik unit will be operational this quarter and we are excited by the clinical talent that has come on board. I am optimistic that we are on track to achieve our targets for FY 25. Result PDF